Desferoxamine (DFO) – Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer | springermedicine.com

Springer Medicine

Top

Journal of Neuro-Oncology

Published in:

01-05-2004

Desferoxamine (DFO) – Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer

Authors: Pouya N. Dayani, Maria C. Bishop, Keith Black, Paul M. Zeltzer

Published in: Journal of Neuro-Oncology | Issue 3/2004

Login to get access

Title: Desferoxamine (DFO) – Mediated Iron Chelation: Rationale for a Novel Approach to Therapy for Brain Cancer
Authors: Pouya N. Dayani
Maria C. Bishop
Keith Black
Paul M. Zeltzer
Publication date: 01-05-2004
Publisher: Kluwer Academic Publishers
Published in: Journal of Neuro-Oncology / Issue 3/2004
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1023/B:NEON.0000024238.21349.37

Home
Congress Coverage
Clinical Collections
- Advances in Alzheimer’s
About Springer Medicine
Key Specialties